Grace Breeding Valuation

Is GRAC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GRAC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GRAC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GRAC's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GRAC?

Key metric: As GRAC barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for GRAC. This is calculated by dividing GRAC's market cap by their current book value.
What is GRAC's PB Ratio?
PB Ratio33.3x
Book₪2.01m
Market Cap₪66.69m

Price to Book Ratio vs Peers

How does GRAC's PB Ratio compare to its peers?

The above table shows the PB ratio for GRAC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average5.9x
XTLB XTL Biopharmaceuticals
8.5xn/a₪85.3m
CANF Can-Fite BioPharma
5.8x47.7%₪53.1m
GFC-M G.F.C Green Fields Capital
0.7xn/a₪115.4m
BONS Bonus BioGroup
8.5xn/a₪130.8m
GRAC Grace Breeding
33.3xn/a₪66.7m

Price-To-Book vs Peers: GRAC is expensive based on its Price-To-Book Ratio (33.3x) compared to the peer average (5.9x).


Price to Book Ratio vs Industry

How does GRAC's PB Ratio compare vs other companies in the Asian Biotechs Industry?

10 CompaniesPrice / BookEstimated GrowthMarket Cap
GRAC 33.3xIndustry Avg. 2.7xNo. of Companies42PB0246810+
10 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: GRAC is expensive based on its Price-To-Book Ratio (33.3x) compared to the Asian Biotechs industry average (2.7x).


Price to Book Ratio vs Fair Ratio

What is GRAC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GRAC PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio33.3x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate GRAC's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies